LON/0R2M (LON/0R2M)

London Stock Exchange: LON/0R2M · USD

$815

+3.16 (+0.4%)· Recorded snapshot

Market cap	61.5B
Revenue (ttm)	11.7B
Net income (ttm)	3.3B
EPS (ttm)	$30.4
P/E (trailing)	20.1x
P/E (forward)	11.5x
Dividend	$2.78 (0.45%)
Volume	227
Beta	0.15

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 11.7B
Net income (ttm): 3.3B
EPS (ttm): $30.4
P/E (trailing): 20.1x
P/E (forward): 11.5x
Market cap: 61.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.5

P25 n/aP50 n/aP75 n/a

Trailing P/E20.1

P25 n/aP50 n/aP75 n/a

ROE14

P25 n/aP50 n/aP75 n/a

ROIC13.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All LON/0R2M indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-10-30
Employees	15,410
Employees change	185
Employees growth	1.22%
Enterprise value	$50.1B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1988
Industry	Biotechnology
Is primary listing	No
ISIN number	US75886F1075
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	$61.5B
Next earnings date	2026-10-30
Price	$814.62
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	lon/0R2M
Website	https://www.regeneron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	21.32x
Average P/E ratio (3Y)	19.22x
Average P/E ratio (5Y)	16.94x
Earnings yield	4.96%
EV/Earnings	15.29x
EV/EBIT	15.9x
EV/EBITDA	14.01x
EV/FCF	17.6x
EV/Sales	4.27x
FCF / EV yield	5.68%
FCF yield	4.63%
Forward P/E	11.52x
Graham number	558.28765
Graham upside	-31.6%
Lynch fair value	$217.42
Lynch upside	-73.36%
P/(FCF - SBC) ratio	29.29x
P/(OCF - SBC) ratio	21.99x
P/B ratio	2.56x
P/E ratio	20.15x
P/FCF ratio	21.61x
P/OCF ratio	17.36x
P/S ratio	5.23x
Price / tangible book value	2.67x
Price/EBITDA ratio	17.28x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	26.87%
EBITDA margin	30.27%
Effective tax rate	16.21%
FCF margin	24.27%
Gross margin	44.46%
Operating margin	26.87%
Pretax margin	33.25%
Profit margin	27.86%
Profit per employee	$211,716
Profitable quarters	55
Profitable years	14
Revenue per employee	$759,799
ROA	6.53%
ROA (5Y)	11.91%
ROCE	11.53%
ROE	14.04%
ROE (5Y)	24.44%
ROIC	13.5%
ROIC (5Y)	28.16%
SBC / revenue	6.35%
Tax / revenue	5.39%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	1.92%
EPS growth (Q)	-4.53%
EPS growth (QoQ)	81.19%
EPS growth 10Y	20.22%
EPS growth 3Y	2.25%
EPS growth 5Y	-6.1%
EPS growth years	2
FCF growth	-2.42%
FCF growth (Q)	-38.1%
FCF growth (QoQ)	-32.48%
FCF growth 3Y	-3.26%
FCF growth 5Y	17.3%
Gross profit growth	2.61%
Gross profit growth (Q)	20.82%
Gross profit growth 3Y	0.47%
Gross profit growth 5Y	-2.58%
Net income growth	-2.91%
Net income growth (Q)	-6.81%
Net income growth (QoQ)	78.34%
Net income growth 3Y	0.23%
Net income growth 5Y	-6.95%
Net income growth years	2
OCF growth	-1.31%
OCF growth (Q)	-28.96%
OCF growth (QoQ)	-24.65%
OCF growth 10Y	11.2%
OCF growth 3Y	-0.41%
OCF growth 5Y	15.56%
Operating income growth	5.49%
Operating income growth (Q)	30.38%
Operating income growth 3Y	-1.89%
Operating income growth 5Y	-8.98%
Revenue growth	9.29%
Revenue growth (Q)	16.74%
Revenue growth (QoQ)	19.01%
Revenue growth 10Y	12.82%
Revenue growth 3Y	7.03%
Revenue growth 5Y	4.64%
Revenue growth quarters	5
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-694.1M
Depreciation and amortization	$397.4M
EBIT	$3.1B
EBITDA	$3.5B
EPS	$30.40
Financing cash flow	$-2.7B
Free cash flow	$2.8B
Free cash flow minus SBC	$2.1B
Gross profit	$5.2B
Income taxes	$631.1M
Investing cash flow	$-530.8M
Net cash flow	$339.5M
Net income	$3.3B
Operating cash flow minus SBC	$2.8B
Operating income	$3.1B
Revenue	$11.7B
Stock-based compensation	$743.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.47
Book value per share	$238.25
Debt / EBITDA	0.57
Debt / equity	0.09
Debt / FCF	0.72
Interest coverage	75.34
Long-term assets	$17.6B
Long-term liabilities	$3.4B
Net cash (debt)	$11.4B
Net cash / market cap	18.6%
Net cash growth	1.98%
Net debt / EBITDA	-3.21
Net debt / equity	-0.48
Net debt / FCF	-4.02
Piotroski F-Score	5
Property, plant and equipment	$4.1B
Shareholders' equity	$23.9B
Tangible book value	$22.9B
Tangible book value per share	$228.41
Total assets	$31.5B
Total cash	$6B
Total debt	$2B
Total liabilities	$7.6B
WACC	4.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.39
Current assets	$13.9B
Current liabilities	$4.2B
Current ratio	3.34
Inventory turnover	2.74
Net working capital	$4.3B
Quick ratio	2.63
Working capital	$9.7B
Working capital turnover	0.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	4.76%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-08-31
Dividend payment years	2
Dividend payout frequency	Quarterly
Dividend per share	$2.78
Dividend yield	0.45%
Ex-dividend date	2026-08-18
Last dividend	$0.94
Payout ratio	8.74%
Shareholder yield	5.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$726.83
1D price change	0.39%
1M price change	3.29%
1M total return	3.29%
1W price change	2.23%
1W total return	2.23%
1Y price change	39.29%
1Y return CAGR	40.03%
1Y total return	40%
20-day SMA	$774.85
200-day SMA	$736.13
3M price change	21.14%
3M total return	21.28%
3Y price change	5.45%
3Y return CAGR	2.1%
3Y total return	6.45%
50-day SMA	$792.45
50-day SMA vs 200-day SMA	50over200
52-week high	$870.00
52-week high date	2026-09-03
52-week low	$588.50
52-week low date	2025-10-28
5Y price change	38.21%
5Y return CAGR	6.89%
5Y total return	39.52%
6M price change	9.3%
6M total return	9.59%
All-time high	$1,210.92
All-time high date	2024-08-27
All-time low	$274.13
All-time low date	2019-10-03
Average true range (ATR)	$30.03
Average volume	552.5
Beta (5Y)	0.15
Change from 52-week high	-6.37%
Change from 52-week low	38.42%
Change from all-time high	-32.78%
Change from all-time low	196.93%
Change from open	-0.18%
Day's gap	0.57%
Dollar volume	$184,919
High price	$828.14
Low price	$800.95
Monthly RSI	55.73
Open price	$816.10
Position in 52-week range	50.28%
Previous close	$811.46
Price vs 150-day SMA	11.99%
Price vs 20-day SMA	5.05%
Price vs 200-day SMA	10.57%
Price vs 50-day SMA	2.72%
Relative volume	0.41
RSI	59.56
Sharpe ratio	1.15
Sharpe ratio (3Y)	0.01
Sharpe ratio (5Y)	0.29
Sortino ratio	1.89
Sortino ratio (3Y)	0.18
Sortino ratio (5Y)	0.59
Volume	227
Weekly RSI	58.84
YTD price change	5.16%
YTD total return	5.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	95.8M
Shares change (QoQ)	-1.58%
Shares change (YoY)	-4.76%
Shares held by insiders	3.83%
Shares held by institutions	93.74%
Short ratio	2.9 days

Deeper analysis on LON/0R2M

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this LON/0R2M report

Is a complete LON/0R2M research report available?

No complete published report is available for lon/0R2M (LON/0R2M) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

61.5B

Revenue (ttm)

11.7B

Net income (ttm)

3.3B

EPS (ttm)

$30.4

P/E (trailing)

20.1x

P/E (forward)

11.5x

Dividend

$2.78 (0.45%)

Volume

227

Beta

0.15

Metric

Value

Amount currency

GBP

Country

United States

Country code

Earnings date

2026-10-30

Employees

15,410

Employees change

185

Employees growth

1.22%

Enterprise value

$50.1B

Exchange

London Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1988

Industry

Biotechnology

Is primary listing

ISIN number

US75886F1075

Last earnings date

2026-07-30

Last refreshed

2026-10-28

Market cap

$61.5B

Next earnings date

2026-10-30

Price

$814.62

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

lon/0R2M

Website

https://www.regeneron.com

Metric

Value

Average P/E ratio (10Y)

21.32x

Average P/E ratio (3Y)

19.22x

Average P/E ratio (5Y)

16.94x

Earnings yield

4.96%

EV/Earnings

15.29x

EV/EBIT

15.9x

EV/EBITDA

14.01x

EV/FCF

17.6x

EV/Sales

4.27x

FCF / EV yield

5.68%

FCF yield

4.63%

Forward P/E

11.52x

Graham number

558.28765

Graham upside

-31.6%

Lynch fair value

$217.42

Lynch upside

-73.36%

P/(FCF - SBC) ratio

29.29x

P/(OCF - SBC) ratio

21.99x

P/B ratio

2.56x

P/E ratio

20.15x

P/FCF ratio

21.61x

P/OCF ratio

17.36x

P/S ratio

5.23x

Price / tangible book value

2.67x

Price/EBITDA ratio

17.28x

Sector forward P/E

14.49x

Sector P/E

22.58x

Metric

Value

EBIT margin

26.87%

EBITDA margin

30.27%

Effective tax rate

16.21%

FCF margin

24.27%

Gross margin

44.46%

Operating margin

26.87%

Pretax margin

33.25%

Profit margin

27.86%

Profit per employee

$211,716

Profitable quarters

Profitable years

Revenue per employee

$759,799

ROA

6.53%

ROA (5Y)

11.91%

ROCE

11.53%

ROE

14.04%

ROE (5Y)

24.44%

ROIC

13.5%

ROIC (5Y)

28.16%

SBC / revenue

6.35%

Tax / revenue

5.39%

Metric

Value

EPS growth

1.92%

EPS growth (Q)

-4.53%

EPS growth (QoQ)

81.19%

EPS growth 10Y

20.22%

EPS growth 3Y

2.25%

EPS growth 5Y

-6.1%

EPS growth years

FCF growth

-2.42%

FCF growth (Q)

-38.1%

FCF growth (QoQ)

-32.48%

FCF growth 3Y

-3.26%

FCF growth 5Y

17.3%

Gross profit growth

2.61%

Gross profit growth (Q)

20.82%

Gross profit growth 3Y

0.47%

Gross profit growth 5Y

-2.58%

Net income growth

-2.91%

Net income growth (Q)

-6.81%

Net income growth (QoQ)

78.34%

Net income growth 3Y

0.23%

Net income growth 5Y

-6.95%

Net income growth years

OCF growth

-1.31%

OCF growth (Q)

-28.96%

OCF growth (QoQ)

-24.65%

OCF growth 10Y

11.2%

OCF growth 3Y

-0.41%

OCF growth 5Y

15.56%

Operating income growth

5.49%

Operating income growth (Q)

30.38%

Operating income growth 3Y

-1.89%

Operating income growth 5Y

-8.98%

Revenue growth

9.29%

Revenue growth (Q)

16.74%

Revenue growth (QoQ)

19.01%

Revenue growth 10Y

12.82%

Revenue growth 3Y

7.03%

Revenue growth 5Y

4.64%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

$-694.1M

Depreciation and amortization

$397.4M

EBIT

$3.1B

EBITDA

$3.5B

EPS

$30.40

Financing cash flow

$-2.7B

Free cash flow

$2.8B

Free cash flow minus SBC

$2.1B

Gross profit

$5.2B

Income taxes

$631.1M

Investing cash flow

$-530.8M

Net cash flow

$339.5M

Net income

$3.3B

Operating cash flow minus SBC

$2.8B

Operating income

$3.1B

Revenue

$11.7B

Stock-based compensation

$743.7M

Metric

Value

Altman Z-Score

6.47

Book value per share

$238.25

Debt / EBITDA

0.57

Debt / equity

0.09

Debt / FCF

0.72

Interest coverage

75.34

Long-term assets

$17.6B

Long-term liabilities

$3.4B

Net cash (debt)

$11.4B

Net cash / market cap

18.6%

Net cash growth

1.98%

Net debt / EBITDA

-3.21

Net debt / equity

-0.48

Net debt / FCF

-4.02

Piotroski F-Score

Property, plant and equipment

$4.1B

Shareholders' equity

$23.9B

Tangible book value

$22.9B

Tangible book value per share

$228.41

Total assets

$31.5B

Total cash

$6B

Total debt

$2B

Total liabilities

$7.6B

WACC

4.98%

Metric

Value

Asset turnover

0.39

Current assets

$13.9B

Current liabilities

$4.2B

Current ratio

3.34

Inventory turnover

2.74

Net working capital

$4.3B

Quick ratio

2.63

Working capital

$9.7B

Working capital turnover

0.9

Metric

Value

Buyback yield / dilution

4.76%

Dividend growth

Dividend growth years

Dividend payment date

2026-08-31

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

$2.78

Dividend yield

0.45%

Ex-dividend date

2026-08-18

Last dividend

$0.94

Payout ratio

8.74%

Shareholder yield

5.21%

Metric

Value

150-day SMA

$726.83

1D price change

0.39%

1M price change

3.29%

1M total return

3.29%

1W price change

2.23%

1W total return

2.23%

1Y price change

39.29%

1Y return CAGR

40.03%

1Y total return

40%

20-day SMA

$774.85

200-day SMA

$736.13

3M price change

21.14%

3M total return

21.28%

3Y price change

5.45%

3Y return CAGR

2.1%

3Y total return

6.45%

50-day SMA

$792.45

50-day SMA vs 200-day SMA

50over200

52-week high

$870.00

52-week high date

2026-09-03

52-week low

$588.50

52-week low date

2025-10-28

5Y price change

38.21%

5Y return CAGR

6.89%

5Y total return

39.52%

6M price change

9.3%

6M total return

9.59%

All-time high

$1,210.92

All-time high date

2024-08-27

All-time low

$274.13

All-time low date

2019-10-03

Average true range (ATR)

$30.03

Average volume

552.5

Beta (5Y)

0.15

Change from 52-week high

-6.37%

Change from 52-week low

38.42%

Change from all-time high

-32.78%

Change from all-time low

196.93%

Change from open

-0.18%

Day's gap

0.57%

Dollar volume

$184,919

High price

$828.14

Low price

$800.95

Monthly RSI

55.73

Open price

$816.10

Position in 52-week range

50.28%

Previous close

$811.46

Price vs 150-day SMA

11.99%

Price vs 20-day SMA

5.05%

Price vs 200-day SMA

10.57%

Price vs 50-day SMA

2.72%

Relative volume

0.41

RSI

59.56

Sharpe ratio

1.15

Sharpe ratio (3Y)

0.01

Sharpe ratio (5Y)

0.29

Sortino ratio

1.89

Sortino ratio (3Y)

0.18

Sortino ratio (5Y)

0.59

Volume

227

Weekly RSI

58.84

YTD price change

5.16%

YTD total return

5.57%

Metric

Value

Float

95.8M

Shares change (QoQ)

-1.58%

Shares change (YoY)

-4.76%

Shares held by insiders

3.83%

Shares held by institutions

93.74%

Short ratio

2.9 days

LON/0R2M (LON/0R2M)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R2M

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R2M indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0R2M

Frequently asked questions

LON/0R2M (LON/0R2M)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R2M

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R2M indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0R2M

Frequently asked questions